sulfur burps and semaglutide on Ozempic: Why They Happen What Helps Ozempic Has a Weird—And Burpy—Side
Description
, -
In the most recent Phase 3 trial (TRIUMPH-4, December 2025), Retatrutide at 12 mg produced 28.7% average weight loss over 68 weeks, translating to roughly 71 pounds lost for the average participant
On average, participants using Semaglutide may experience around 15% weight loss of their body weight, while those on Tirzepatide can expect around 20% weight loss
10.1161/ATVBAHA.113.301586
The intersection of hyperthyroidism and obesity creates a clinical scenario where standard weight loss interventions may backfire
Figure 3 Since entry into the clinic, research on GLP-1 has continued, unveiling new mechanisms behind the various benefits of GLP-1R agonists, as well as possible new applications in other conditions
